Cargando…

Molecular Iodine/Cyclophosphamide Synergism on Chemoresistant Neuroblastoma Models

Neuroblastoma (Nb), the most common extracranial tumor in children, exhibited remarkable phenotypic diversity and heterogeneous clinical behavior. Tumors with MYCN overexpression have a worse prognosis. MYCN promotes tumor progression by inducing cell proliferation, de-differentiation, and dysregula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Álvarez-León, Winniberg, Mendieta, Irasema, Delgado-González, Evangelina, Anguiano, Brenda, Aceves, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396562/ https://www.ncbi.nlm.nih.gov/pubmed/34445656 http://dx.doi.org/10.3390/ijms22168936

Ejemplares similares

Molecular Iodine Has Extrathyroidal Effects as an Antioxidant, Differentiator, and Immunomodulator
por: Aceves, Carmen, et al.
Publicado: (2021)

Molecular iodine exerts antineoplastic effects by diminishing proliferation and invasive potential and activating the immune response in mammary cancer xenografts
por: Mendieta, Irasema, et al.
Publicado: (2019)

Molecular Iodine Supplement Prevents Streptozotocin-Induced Pancreatic Alterations in Mice
por: Rodríguez-Castelán, Julia, et al.
Publicado: (2022)

Iodine and doxorubicin, a good combination for mammary cancer treatment: antineoplastic adjuvancy, chemoresistance inhibition, and cardioprotection
por: Alfaro, Yunuen, et al.
Publicado: (2013)

Effects of Molecular Iodine/Chemotherapy in the Immune Component of Breast Cancer Tumoral Microenvironment
por: Cuenca-Micó, Olga, et al.
Publicado: (2021)

Preventive Effect of Molecular Iodine in Pancreatic Disorders from Hypothyroid Rabbits
por: Rodríguez-Castelán, Julia, et al.
Publicado: (2023)

Prostate gland as a target organ of thyroid hormones: advances and controversies
por: Anguiano, Brenda, et al.
Publicado: (2022)

Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer
por: Zambrano-Estrada, Xóchitl, et al.
Publicado: (2018)

Adjuvant Effect of Molecular Iodine in Conventional Chemotherapy for Breast Cancer. Randomized Pilot Study
por: Moreno-Vega, Aura, et al.
Publicado: (2019)

SAT-561 Protective Effect of Moderated Dose of Iodine in Pancreatic Alterations during Hypothyroidism
por: Rodríguez-Castelán, Julia, et al.
Publicado: (2019)

Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)
por: Aceves, Carmen, et al.
Publicado: (2009)

Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma
por: Gershan, Jill A., et al.
Publicado: (2015)

Autophagy is associated with chemoresistance in neuroblastoma
por: Belounis, Assila, et al.
Publicado: (2016)

Identification of miRNAs contributing to neuroblastoma chemoresistance
por: Ayers, Duncan, et al.
Publicado: (2015)

Neuroendocrine Differentiation of Lung Cancer Cells Impairs the Activation of Antitumor Cytotoxic Responses in Mice
por: Fosado, Ricardo, et al.
Publicado: (2023)

Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells
por: Jemaà, Mohamed, et al.
Publicado: (2020)

Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2021)

Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
por: Rodrigo, Miguel Angel Merlos, et al.
Publicado: (2021)

Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity
por: Veltman, Joris D., et al.
Publicado: (2010)

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
por: Mañas, Adriana, et al.
Publicado: (2022)

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
por: Kroesen, Michiel, et al.
Publicado: (2016)

An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance
por: Carta, Alessia, et al.
Publicado: (2014)

Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
por: Buhagiar, Alfred, et al.
Publicado: (2015)

Single-cell transcriptomics of neuroblastoma identifies chemoresistance-associated genes and pathways
por: Avitabile, Marianna, et al.
Publicado: (2022)

Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma
por: Hastings, Jordan F., et al.
Publicado: (2023)

Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901
por: Walter, Steffen, et al.
Publicado: (2013)

Cyclophosphamide in combination with tumor lysate and TLR9 ligand regresses murine neuroblastoma
por: Gershan, Jill, et al.
Publicado: (2013)

Evodiamine Synergizes with Doxorubicin in the Treatment of Chemoresistant Human Breast Cancer without Inhibiting P-Glycoprotein
por: Wang, Shengpeng, et al.
Publicado: (2014)

Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer
por: Bigoni-Ordóñez, Gabriele Davide, et al.
Publicado: (2018)

Treatment of a chemoresistant neuroblastoma cell line with the antimalarial ozonide OZ513
por: Coulter, Don W., et al.
Publicado: (2016)

Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
por: Alfei, Silvana, et al.
Publicado: (2020)

Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis
por: Shmakova, Anna A., et al.
Publicado: (2022)

Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance
por: Ridinger, Johannes, et al.
Publicado: (2018)

Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model
por: Morscher, Raphael Johannes, et al.
Publicado: (2016)

Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
por: Kayano, Daiki, et al.
Publicado: (2015)

Molecular iodine
por: Riad, A., et al.
Publicado: (2020)

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
por: Navarro, Sandi L., et al.
Publicado: (2022)

Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
por: De Ioris, Maria Antonietta, et al.
Publicado: (2023)

Investigation of chemoresistance to first-line chemotherapy and its possible association with autophagy in high-risk neuroblastoma
por: Chen, Tingting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_30vq3hohedu1d6a1e6pct65ku6